Gender differences in the surgical management of trachomatous trichiasis: an exploratory analysis of global trachoma survey data, 2015-2019
- PMID: 38048383
- PMCID: PMC10695456
- DOI: 10.1093/inthealth/ihad067
Gender differences in the surgical management of trachomatous trichiasis: an exploratory analysis of global trachoma survey data, 2015-2019
Abstract
Background: Trachomatous trichiasis (TT) is a painful, potentially blinding eye condition that can be managed through epilation or surgery. Women are affected by TT approximately twice as often as men and are believed to face gendered barriers to receiving surgical care to prevent vision loss.
Methods: We used data from 817 cross-sectional surveys conducted during 2015-2019 in 20 African countries to estimate the prevalence difference (PD) between female and male eyes for four outcomes potentially indicating gender-related differences in TT management: (1) received surgery and developed postoperative TT (PTT), (2) never offered surgery, (3) offered surgery but declined it, and (4) offered epilation but never offered surgery.
Results: The prevalence was modestly elevated among female eyes compared with male eyes for having PTT (PD:1.8 [95% confidence limits (CL): 0.6, 3.0]) and having declined surgery for the eye (PD: 6.2 [95% CL: 1.8, 10.7]). The proportion offered epilation was similar by gender (PD:0.5 [95% CL: -0.4, 1.3]), while never having been offered surgery was somewhat more prevalent among male eyes (PD: -2.1 [95% CL: -3.5, -0.7]).
Conclusions: Our results suggest potential gender differences in TT management. More research is needed to determine the causes and implications of the observed differences.
Keywords: Chlamydia trachomatis; elimination; gender; surgery; trachoma; trichiasis.
© The Author(s) 2023. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
Conflict of interest statement
CM and MD are Guest Editors of this supplement but had no role in the review of this manuscript. AB is employed by the International Trachoma Initiative at The Task Force for Global Health, which receives an operating budget and research funds from Pfizer Inc., the manufacturers of Zithromax (azithromycin); EMHE is funded by the International Trachoma Initiative, a program of The Task Force for Global Health, which receives funding from Pfizer Inc., the manufacturers of Zithromax (azithromycin). All other authors have no completing interests to declare. The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated, USAID or the United States Government.
Figures
References
-
- WHO Alliance for the Global Elimination of Trachoma: Progress report on elimination of trachoma, 2021. Wkly Epidemiol Rec. 2022;97:353–64.
-
- World report on vision. Geneva, Switzerland: World Health Organization; 2019.
-
- Cromwell EA, Courtright P, King JDet al. The excess burden of trachomatous trichiasis in women: A systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2009;103(10):985–92. - PubMed